Results 241 to 250 of about 68,243 (289)

Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper

open access: yesESC Heart Failure, EarlyView.
The graphical abstract summarizes the key features of AFMR in terms of epidemiology, pathophysiology, diagnosis, medical therapy and rhythm control, surgical and transcatheter interventions, and future directions. Created in BioRender (https://BioRender.com/3zj03ko).
Matteo Pagnesi   +14 more
wiley   +1 more source

Reply to 'Cost-effectiveness of long term left ventricular assist devices'. [PDF]

open access: yesNeth Heart J
Wiethoff I   +6 more
europepmc   +1 more source

First evaluation of a novel pulsatile LVAD: Feasibility and haemodynamic impact in acute heart failure

open access: yesESC Heart Failure, EarlyView.
The pulsatile ventricular assist platform (pVAP) was connected to a membrane pump in six large swine models. The system, driven by a conventional intra‐aortic balloon pump console (IABP), was utilized to drain left atrial blood during systole and to eject the collected blood back into the ascending aorta during diastole.
Sara Knigge   +11 more
wiley   +1 more source

Transcatheter Aortic Valve Replacement for Aortic Regurgitation in Patients with Left Ventricular Assist Devices: An Institutional Experience. [PDF]

open access: yesJ Soc Cardiovasc Angiogr Interv
Bashir H   +10 more
europepmc   +1 more source

Four decades of heart–lung transplantation: Milestones and outcomes in advanced cardiorespiratory failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Heart–lung transplantation (HLTx) remains a life‐saving intervention for patients with end‐stage cardiopulmonary failure. We retrospectively analysed long‐term HLTx outcomes at our centre to assess survival trends and evaluate the impact of evolving immunosuppressive, surgical and perioperative strategies.
L. Lily Rosenthal   +10 more
wiley   +1 more source

Impact of extracellular matrix scaffold on driveline infection rate in patients with left ventricular assist devices. [PDF]

open access: yesJTCVS Open
Akay MH   +9 more
europepmc   +1 more source

Percutaneous endocardial alginate–hydrogel injection in the treatment of heart failure: First‐in‐human study

open access: yesESC Heart Failure, EarlyView.
Using EndoWings™ and XDROP™, we developed a percutaneous minimally invasive technique for sequential circumferential alginate hydrogel injection into LV free mid‐wall. This human study assessed its safety/feasibility in HFrEF patients, with personalised biomechanical models.
Bo Wang   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy